During the past decade, Institut Thoracique de Montreal conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut Thoracique de Montreal" are "Asthma" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Institut Thoracique de Montreal" in a lesser frequency.

Most popular intervention types in "Institut Thoracique de Montreal" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ASM8" (1 trials), "Abacavir sulfate" (1 trials), "Aldesleukin" (1 trials), "Didanosine" (1 trials) and "Efavirenz" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Thoracique de Montreal" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut Thoracique de Montreal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Thoracique de Montreal, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Thoracique de Montreal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".